6533b831fe1ef96bd12982fb

RESEARCH PRODUCT

Timing of Renal Replacement Therapy for Severe Acute Kidney Injury in Critically Ill Patients

Didier DreyfussDidier DreyfussDavid HajageDavid HajageJean-pierre QuenotJean-pierre QuenotSaber BarbarJean-damien RicardJean-damien RicardStéphane GaudryStéphane GaudryAlexandre HertigAlexandre Hertig

subject

Pulmonary and Respiratory Medicinemedicine.medical_specialtyHyperkalemiamedicine.medical_treatmentRenal functionurologic and male genital diseasesCritical Care and Intensive Care Medicinelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicine030212 general & internal medicineRenal replacement therapyIntensive care medicinebusiness.industryAcute kidney injurymedicine.diseasePulmonary edemafemale genital diseases and pregnancy complications030228 respiratory systemObservational studymedicine.symptombusinessWatchful waiting

description

Acute kidney injury (AKI) affects many ICU patients and is responsible for increased morbidity and mortality. Although lifesaving in many situations, renal replacement therapy (RRT) may be associated with complications, and the appropriate timing of its initiation is still the subject of intense debate. An early initiation strategy can prevent some metabolic complications, whereas a delayed one may allow for renal function recovery in some patients without need for this costly and potentially dangerous technique. For years, most of the knowledge on this issue stemmed from observational studies or small randomized controlled trials. Recent randomized controlled trials have indicated that a watchful waiting strategy (in the absence of life-threatening conditions such as severe hyperkalemia or pulmonary edema) during severe AKI allowed many patients to escape RRT and did not seem to adversely affect survival compared with a strategy of immediate RRT. In addition, data suggest that a delayed strategy may reduce the rate of complications (such as catheter infection) and favor renal function recovery. Ongoing studies will have to both confirm these conclusions and clarify to what extent the delay in initiating RRT can be prolonged. Pending those results, the bulk of evidence suggests that, in the absence of potential severe complications of AKI, delaying RRT is a valid and safe strategy that may also allow for considerable cost savings.

https://doi.org/10.1164/rccm.201810-1906cp